Test of LED System that Warns Drivers of Black Ice Under Way in Susono, Japan
2.3.2023 15:32:00 EET | Business Wire | Press release
Susono City, Stanley Electric Co., Ltd., Kaga FEI Co., Ltd., NTT Communications Corporation and Dassault Systèmes K.K.. announced jointly today that a system for warning drivers about transparent ("black") ice using a smart streetlight developed by the four companies is being tested on a public road in Susono, Japan from February 10 to March 31. The test will verify the effectiveness of the system in preventing car slippage and pedestrian falls in a public area of Susono.
For the test, a smart streetlight that projects an illuminated warning ("Caution Ice") on the road surface was installed on a light pole in front of Yanagibata Bridge in Ishiwaki, Susono City. During the test, data from an edge AI camera and sensors mounted on the smart streetlight are being collected and transmitted via mobile communication to a center for analysis, including by comparing the number of ice-related accidents at the site before and after the test. Also, residents will be surveyed to see if their awareness of ice-related hazards is changed by the operation of the system.
The roles of each company are as follow:
Stanley Electric:
- Develop, manufacture and supply LED streetlight and illumination-projection equipment
Kaga FEI:
- Provide edge AI camera and sensors
- Develop embedded AI system
NTT Communications:
- Implement mobile communications (IoT Connect Mobile® TypeS1)
- Provide platform for visualizing and storing collected data (Things Cloud®2)
Dassault Systèmes:
- Provide virtual twin3 platform (3DEXPERIENCE© platform)
- Build virtual twins, data visualization, and scenario analysis based on system and terrain data
Once the system is demonstrated to be fully reliable and effective, its broad deployment in other municipalities will be promoted along with the use of smart streetlights in emerging countries where road lighting is uncommon. In addition, by combining data from the system with weather data, etc., it will be possible to provide enhanced weather-related driving information, such as traffic congestion forecasts in areas where snow is expected, keeping drivers better informed while also supporting the work of road and traffic managers.
NTT Com's KOEL4 design studio will join the project to help research opportunities for commercial applications. It is expected that the system could be applied in business areas such as shopping malls and other commercial facilities as well as Park-PFI, a publicly solicited, privately financed initiative for the maintenance and management of urban parks in Japan.
Susono, which has adopted the slogan "Japan's most citizen-oriented city hall," is actively modernizing its urban areas through the introduction of universal-design pedestrian spaces, advanced technology and data analysis, aiming to realize zero fatalities and less than 200 injuries due to accidents per year by 2025.
1 IoT Connect Mobile® TypeS is an eSIM-based mobile data communication service.
2 Things Cloud® is an IoT platform that packages data collection, visualization, analysis and management functions via connected sensors and devices tailored to specific business environments.
3 Virtual twin, more than a digital copy of the real world, is a representation of the real world based on mathematical models and scientific principles.
4 The KOEL design studio was established in April 2020 within NTT Com's Innovation Center, which is dedicated to the creation of new businesses.
About Stanley Electric
Stanley Electric Co., Ltd. was founded in 1920 to manufacture and sell automotive light bulbs and other specialty light bulbs. Today, the company is highly regarded worldwide for products it supplies to major automobile manufacturers. Starting with the world's first commercial high-brightness LEDs in 1976, the company has developed numerous components and other electronic that contribute to safety and energy conservation, including smart streetlights. Please visit https://www.stanley.co.jp/
About Kaga FEI
Kaga FEI Co., Ltd. is an electronics trading company that sells consumer and industrial electronic devices and products for automobiles, AV equipment, communications equipment and information processing equipment. The company and its global partners also provide technical support and solution services that combine commercial products and technologies, including electronics manufacturing services, in markets worldwide. Please visit https://www.kagafei.com/jp/
About NTT Communications
NTT Communications solves global technology challenges by helping enterprises utilize managed IT-infrastructure solutions to overcome complexity and risk in their IT environments. These solutions are backed by our worldwide infrastructure, including industry-leading, global tier-1 public and private networks reaching over 190 countries/regions, and more than 500,000m2 of the world's most advanced data-center facilities. As the core provider of the DOCOMO group's enterprise-business services and solutions, we create value by providing global-scale support for restructuring in industry and society, new workstyles and digital transformation in communities. Together with NTT Ltd., NTT Data and NTT DOCOMO, we are the NTT Group.
www.ntt.com | Twitter@NTT Com | Facebook@NTT Com
About Dassault Systèmes
Dassault Systèmes, the 3DEXPERIENCE Company, is a catalyst for human progress. We provide business and people with collaborative virtual environments to imagine sustainable innovations. By creating 'virtual twin experiences’ of the real world with our 3DEXPERIENCE platform and applications, our customers push the boundaries of innovation, learning and production.
Dassault Systèmes’ 20,000 employees are bringing value to more than 300,000 customers of all sizes, in all industries, in more than 140 countries. For more information, visit https://www.3ds.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230301006236/en/
Contact information
For more information
Susono
Business: Strategic Promotion Division
+81-55-995-1804; kikaku@city.susono.shizuoka.jp
Road management: Construction Management Division
+81-55-995-1855; kanri@city.susono.shizuoka.jp
Stanley Electric
Yokohama Technical Center, Lighting Application Division
+81-45-910-6629
Kaga FEI
Partner Business Promotion Department
System Business Center, Solutions Division
ml-snk_colbiz_pj@jp.kagafei.com
NTT Communications
Business Solution Division, Business Solution Department
bbx-5bs3g@ntt.com
Dassault Systèmes
Marketing Representative, Public Relations Division
+81-3-4321-3506; japan.marketing@3ds.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 16:00:00 EEST | Press release
NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%. A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 15:00:00 EEST | Press release
Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consistent approach to protecting our innovation and our customers,” said Justin Ferguson, SVP and general counsel at Adtran. “We take all claims seriously, but we will not hesitate to defend ourselves when assertions lack merit. Situations like this place unnecessary strain on technology providers and divert resources from advancing networks and services. By advancing our counterclaim
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 14:00:00 EEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 13:50:00 EEST | Press release
IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio transformation and is expected to strengthen the company’s focus on its innovation-driven businesses: Taste, Scent, and Health & Biosciences. Following the transaction, IFF will be
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 13:00:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 patients, underscoring consistent effectiveness and safety in clinical practice. Additionally, BEQALZI™ (sonrotoclax), which was recently approved by the U.S. Food and Drug Administration, and its development in combination with BRUKINSA (ZS) highlight the potential for next-generation, time-limited treatment approaches in CLL. Amit Agarwal, M.D., Ph.D., Chief Medical Officer, Hematology, BeOne Medicines, said: “CLL is a disease patients live with
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom